Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 10Prostatic Neoplasms 4Colorectal Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 3Papillomavirus Infections 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Obesity-Related Malignant Neoplasm 2Lymphoma 2Hematologic Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Skin Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1No Evidence of Disease 1Multiple Myeloma 1Melanoma 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Healthy Subject 1Genital Neoplasms, Female 1Endometrial Neoplasms 1Diabetes Mellitus 1Coronary Artery Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Dexamethasone 115Lenalidomide 74daratumumab 57Bortezomib 52carfilzomib 41Calcium Dobesilate 36pomalidomide 35Cyclophosphamide 26isatuximab 23belantamab mafodotin 22Specimen Handling 20Biopsy 20Magnetic Resonance Spectroscopy 17dexamethasone acetate 13dexamethasone 21-phosphate 13auricularum 12ixazomib 11iberdomide 11fludarabine 11elotuzumab 11selinexor 10Melphalan 10fludarabine phosphate 8talquetamab 7X-Rays 7trametinib 6nirogacestat 6venetoclax 5Thalidomide 5Nuclear Medicine Department, Hospital 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Multiple Myeloma × Early Intervention, Educational × Clear all
NCT03141437 2026-04-24

Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
130 enrolled
BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Genital Neoplasms, Female, Lymphoma, Multiple Myeloma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡